Diversified Trust Co Buys 2,135 Shares of Transcat, Inc. (NASDAQ:TRNS)

Diversified Trust Co boosted its stake in Transcat, Inc. (NASDAQ:TRNS) by 53.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,120 shares of the scientific and technical instruments company’s stock after purchasing an additional 2,135 shares during the period. Diversified Trust Co’s holdings in Transcat were worth $647,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of TRNS. Principal Financial Group Inc. increased its stake in shares of Transcat by 8.8% in the third quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company’s stock valued at $557,000 after buying an additional 373 shares during the period. Virtu Financial LLC grew its holdings in Transcat by 127.0% during the 3rd quarter. Virtu Financial LLC now owns 4,136 shares of the scientific and technical instruments company’s stock worth $499,000 after acquiring an additional 2,314 shares during the last quarter. Geode Capital Management LLC increased its position in Transcat by 5.4% in the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock valued at $26,269,000 after acquiring an additional 11,106 shares during the period. Barclays PLC increased its position in Transcat by 393.0% in the 3rd quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company’s stock valued at $1,826,000 after acquiring an additional 12,061 shares during the period. Finally, State Street Corp raised its stake in shares of Transcat by 8.1% during the third quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock valued at $25,027,000 after acquiring an additional 15,514 shares during the last quarter. Institutional investors own 98.34% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. HC Wainwright reissued a “buy” rating and issued a $156.00 price objective on shares of Transcat in a research note on Tuesday, October 29th. Oppenheimer reiterated an “outperform” rating and issued a $130.00 price target (down previously from $155.00) on shares of Transcat in a research report on Wednesday, October 30th. Northland Securities lowered their price objective on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research report on Wednesday, October 30th. StockNews.com cut Transcat from a “hold” rating to a “sell” rating in a report on Tuesday, October 29th. Finally, Craig Hallum increased their target price on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $130.25.

Transcat Price Performance

Shares of Transcat stock opened at $102.60 on Friday. The firm has a market cap of $943.82 million, a price-to-earnings ratio of 51.82 and a beta of 0.71. The stock’s 50-day moving average is $105.91 and its 200 day moving average is $117.02. Transcat, Inc. has a one year low of $94.29 and a one year high of $147.12.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.12). The company had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. Transcat had a net margin of 6.63% and a return on equity of 7.36%. The business’s revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.41 EPS. On average, sell-side analysts expect that Transcat, Inc. will post 1.76 EPS for the current fiscal year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.